Obstructive sleep apnea in late-onset Pompe disease treated by enzyme replacement therapy.
Publication
, Journal Article
Bhui, R; Spector, AR
Published in: Neuromuscul Disord
April 2020
Obstructive sleep apnea is a common complication of Pompe disease. Treatment for obstructive sleep apnea in patients with Pompe disease is similar to treatment in the general population, typically involving positive airway pressure therapy. We present a case in which a patient with late-onset Pompe disease was able to discontinue positive airway pressure therapy after treatment with enzyme replacement therapy for his Pompe disease. It is likely that an improvement in muscle tone from the enzyme replacement therapy was sufficient to eliminate his obstructive sleep apnea. Pharmacological therapies for obstructive sleep apnea are lacking but could apply to certain populations, such as Pompe disease.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Neuromuscul Disord
DOI
EISSN
1873-2364
Publication Date
April 2020
Volume
30
Issue
4
Start / End Page
329 / 330
Location
England
Related Subject Headings
- Sleep Apnea, Obstructive
- Neurology & Neurosurgery
- Male
- Humans
- Glycogen Storage Disease Type II
- Enzyme Replacement Therapy
- Adult
- 5202 Biological psychology
- 3209 Neurosciences
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Bhui, R., & Spector, A. R. (2020). Obstructive sleep apnea in late-onset Pompe disease treated by enzyme replacement therapy. Neuromuscul Disord, 30(4), 329–330. https://doi.org/10.1016/j.nmd.2020.02.004
Bhui, Raj, and Andrew R. Spector. “Obstructive sleep apnea in late-onset Pompe disease treated by enzyme replacement therapy.” Neuromuscul Disord 30, no. 4 (April 2020): 329–30. https://doi.org/10.1016/j.nmd.2020.02.004.
Bhui R, Spector AR. Obstructive sleep apnea in late-onset Pompe disease treated by enzyme replacement therapy. Neuromuscul Disord. 2020 Apr;30(4):329–30.
Bhui, Raj, and Andrew R. Spector. “Obstructive sleep apnea in late-onset Pompe disease treated by enzyme replacement therapy.” Neuromuscul Disord, vol. 30, no. 4, Apr. 2020, pp. 329–30. Pubmed, doi:10.1016/j.nmd.2020.02.004.
Bhui R, Spector AR. Obstructive sleep apnea in late-onset Pompe disease treated by enzyme replacement therapy. Neuromuscul Disord. 2020 Apr;30(4):329–330.
Published In
Neuromuscul Disord
DOI
EISSN
1873-2364
Publication Date
April 2020
Volume
30
Issue
4
Start / End Page
329 / 330
Location
England
Related Subject Headings
- Sleep Apnea, Obstructive
- Neurology & Neurosurgery
- Male
- Humans
- Glycogen Storage Disease Type II
- Enzyme Replacement Therapy
- Adult
- 5202 Biological psychology
- 3209 Neurosciences
- 3202 Clinical sciences